Skip to Main Content

Author Details

Douglas A Kerr
Johns Hopkins University School of Medicine
1990
91
41
PMIDPaper TitleJournal TitlePublished Year
25384682Commonalities and challenges in the development of clinical trial measures in neurology.Neurotherapeutics2015
25608934Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in Neurology.Neurotherapeutics2015
22985432Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: subgroup analysis of demographic and clinical characteristics.Amyotroph Lateral Scler Frontotemporal Degener2013
24499173Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database.BMC Neurol2013
24067398Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.Lancet Neurol2013
23323713The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.Amyotroph Lateral Scler Frontotemporal Degener2013
21865410Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.Mult Scler2012
22760029Derivation of glial restricted precursors from E13 mice.J Vis Exp2012
22923719Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor.Radiology2012
22508097Noninvasive monitoring of immunosuppressive drug efficacy to prevent rejection of intracerebral glial precursor allografts.Cell Transplant2012
20532646n-Dodecyl-β-D-maltoside inhibits aggregation of human interferon-β-1b and reduces its immunogenicity.J Neuroimmune Pharmacol2011
21358440High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.Medicine (Baltimore)2011
21264955Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination.Glia2011
20404843Stem cell transplantation in multiple sclerosis: current status and future prospects.Nat Rev Neurol2010
21096668Histogram based quantification of spinal cord injury level using somatosensory evoked potentials.Annu Int Conf IEEE Eng Med Biol Soc2010
20810997Associations between retinal nerve fiber layer abnormalities and optic nerve examination.Neurology2010
20871141A pilot study of functional electrical stimulation cycling in progressive multiple sclerosis.NeuroRehabilitation2010
20538464Slope analysis of somatosensory evoked potentials in spinal cord injury for detecting contusion injury and focal demyelination.J Clin Neurosci2010
20508959Evoked potential and behavioral outcomes for experimental autoimmune encephalomyelitis in Lewis rats.Neurol Sci2010
20227773Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity.J Neuroimmunol2010
18728679The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.J Cereb Blood Flow Metab2009
19877037Distinct subtypes of myelitis in systemic lupus erythematosus.Arthritis Rheum2009
19636050Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.Neurology2009
19597093Priapism in infantile transverse myelitis.Arch Neurol2009
19752308Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus.Arch Neurol2009
19396681Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges.Am J Bioeth2009
19368827Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis.Brain Res2009
19423134Effect of MOG sensitization on somatosensory evoked potential in Lewis rats.J Neurol Sci2009
19383644Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.Mult Scler2009
19514076Using global statistical tests in long-term Parkinson's disease clinical trials.Mov Disord2009
18195153Ethanol responsive tremor in a patient with multiple sclerosis.Arch Neurol2008
18541787Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.Arch Neurol2008
18463365Cell-based interventions for neurologic conditions: ethical challenges for early human trials.Neurology2008
18493269Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus.Nat Clin Pract Rheumatol2008
18582952Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.J Neuroimmunol2008
18510734Neuromyelitis optica pathogenesis and aquaporin 4.J Neuroinflammation2008
18227415Finding NMO: neuromyelitis optica in children.Neurology2008
18281453Thymic hyperplasia in a patient with recurrent transverse myelitis with clinical resolution after thymectomy.J Neurol Neurosurg Psychiatry2008
18410928Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration.Exp Neurol2008
18417225Interleukin-17 in transverse myelitis and multiple sclerosis.J Neuroimmunol2008
18063113Cleavage of myelin associated glycoprotein by matrix metalloproteinases.J Neuroimmunol2008
17485649Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide.Neurology2007
17562944Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters".Arch Neurol2007
17557778High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord.Brain2007
176518172006 rare neuroimmunological disorders symposium; Sheraton Inner Harbor, Baltimore, MD, July 20-23, 2006.J Neuroimmunol2007
17710103Thalidomide for acute treatment of neurosarcoidosis.Spinal Cord2007
17726912Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.Dialogues Clin Neurosci2007
17330284Devic's syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody.Arthritis Rheum2007
17470749Acute transverse myelitis in childhood: center-based analysis of 47 cases.Neurology2007
16691560Altered immune response to CNS viral infection in mice with a conditional knock-down of macrophage-lineage cells.Glia2006
  • 1 - 50 of 91

Recommended Authors

University of Arizona College of Medicine
Career Start Year 2013
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Columbia University Medical Center
Career Start Year 2012
Number of shared co-authors 1
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig Maximilians University
Career Start Year 2009
Number of shared co-authors 5
Boston Children's Hospital, Harvard Medical School
Career Start Year 2007
Number of shared co-authors 1
St. Vincent's University Hospital
Career Start Year 2007
Number of shared co-authors 0
Yale University
Career Start Year 2005
Number of shared co-authors 2
Concord Repatriation General Hospital
Career Start Year 1998
Number of shared co-authors 4
College of Medicine, Mayo Clinic
Career Start Year 1998
Number of shared co-authors 0
Moorfields Eye Hospital
Career Start Year 1998
Number of shared co-authors 5
Brigham and Women's Hospital
Career Start Year 1998
Number of shared co-authors 0
Technical University of Munich
Career Start Year 1995
Number of shared co-authors 5
University of California san francisco
Career Start Year 1995
Number of shared co-authors 4
Hospital Clinic of Barcelona-Institut d'Investigacions
Career Start Year 1994
Number of shared co-authors 5
University of Pennsylvania/Ophthalmology
Career Start Year 1993
Number of shared co-authors 3
University of Massachusetts Medical School
Career Start Year 1993
Number of shared co-authors 4
Tokyo Women's Medical University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
McMaster University
Career Start Year 1991
Number of shared co-authors 0
The Ohio State University Wexner Medical Center
Career Start Year 1991
Number of shared co-authors 6
University of Washington School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1985
Number of shared co-authors 2
Biomedicine and Clinical Research, University Hospital Basel, University of Basel
Career Start Year 1985
Number of shared co-authors 1
Indiana University School of Medicine, Indiana University Health
Career Start Year 1984
Number of shared co-authors 2
Ann & Robert H. Lurie Children's Hospital of Chicago
Career Start Year 1983
Number of shared co-authors 4
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 4
Department of Neurology and NYU Grossman School of Medicine
Career Start Year 1982
Number of shared co-authors 5
Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1980
Number of shared co-authors 5
Tsudanuma Neurology Clinic.
Career Start Year 1979
Number of shared co-authors 0
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Career Start Year 1977
Number of shared co-authors 6
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Johns Hopkins University School of Medicine
Co-authored papers 14
Co-authored papers 7
Co-authored papers 7
Johns Hopkins School of Medicine
Co-authored papers 5
Johns Hopkins School of Medicine
Co-authored papers 5
University of Colorado
Co-authored papers 4
The University of Texas Southwestern Medical Center
Co-authored papers 4
Johns Hopkins Hospital
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 4
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 3
Berman Institute of Bioethics, Johns Hopkins University
Co-authored papers 3
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
W.M. Keck Center for Collaborative Neuroscience, The State University of New Jersey
Co-authored papers 3
Phoebe R Berman Bioethics Institute
Co-authored papers 3
The Center for Law and the Biosciences, Stanford University
Co-authored papers 3
Harvard Medical School and McLean Hospital
Co-authored papers 3
New York University.
Co-authored papers 3
Johns Hopkins University School of Medicine Abarbanel Mental Health Centre
Co-authored papers 3
Johns Hopkins Berman Institute of Bioethics
Co-authored papers 3
Stanford University School of Medicine
Co-authored papers 3
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 3
IRCCS Casa Sollievo della Sofferenza, University of Milano-Bicocca
Co-authored papers 3
Berman Institute of Bioethics, Johns Hopkins University
Co-authored papers 3
Co-authored papers 3
Johns Hopkins University, Berman Institute of Bioethics
Co-authored papers 3
Johns Hopkins University
Co-authored papers 3
Marcus Center for Cellular Cures, Duke University School of Medicine
Co-authored papers 3
New York Presbyterian Hospital, Columbia University Medical Center
Co-authored papers 3
National Institutes of Health, National Institute of Neurological Diseases and Stroke
Co-authored papers 3